Histopathology-guided management of ocular surface squamous neoplasia with corneal stromal or scleral invasion using ruthenium-106 plaque brachytherapy.

Raksha RaoSantosh G HonavarSumeet LahaneKaustubh MulayVijayanand Palkonda Reddy

Published in: The British journal of ophthalmology (2021)

Histopathology-guided use of Ru-106 surface plaque brachytherapy is a safe and an effective adjuvant therapy in the management of corneal stromal and/or scleral invasion of OSSN.

Keyphrases

high dose
high grade
radiation therapy
bone marrow
cell migration
coronary artery disease
optical coherence tomography
wound healing
locally advanced
low grade
squamous cell carcinoma
energy transfer